Scorecard › GOOGL
GOOGL analyst scorecard · Alphabet Inc. (Class A)
160 rating actions on GOOGL in the last 12 months. Of 250 price targets that resolved, 108 were reached while they stood, 142 were replaced by the same firm first, and 0 fell short at their deadline. Ratings: 82% Buy-type, 18% Hold-type, 0% Sell-type. Consensus target $420, 48% above the last close.
Checked through 2026-10-29 · last close $282.94 (2026-10-29). Rebuilt every morning.
Targets reached while they stood
43.2% 108 of 250
Replaced before the deadline
56.8%
Short at the deadline
0.0%
Ratings vs XLC
32 of 32
Buy / Hold / Sell, 12 mo
82 / 18 / 0%
Consensus target
$420 +48.4%
What the Holds say: 27 Hold-type ratings on GOOGL in the last 12 months carried a median target +7% from the price on the day; 15% sat below it.
The 3 upgrades on GOOGL came after an average -1.2% move in the 30 days before them.
Firm by firm
| Firm | Latest rating | Date | Latest target | Targets reached | Replaced early | Resolved | Ratings vs sector |
|---|---|---|---|---|---|---|---|
| Wedbush | Outperform | 2026-10-29 | $387 | 5 | 3 | 8 | 1 of 1 |
| BMO Capital | Outperform | 2026-10-20 | $480 | 3 | 7 | 10 | 1 of 1 |
| Needham | Buy | 2026-10-29 | $450 | 7 | 9 | 16 | 1 of 1 |
| Citigroup | Buy | 2026-04-30 | $447 | 2 | 8 | 10 | 1 of 1 |
| Wells Fargo | Overweight | 2026-10-06 | $417 | 3 | 10 | 13 | — |
| Citizens | Market Perform | 2026-10-29 | $450 | 3 | 3 | 6 | — |
| Cantor Fitzgerald | Overweight | 2026-10-29 | $350 | 5 | 8 | 13 | — |
| Morgan Stanley | Overweight | 2026-10-29 | $375 | 4 | 6 | 10 | 1 of 1 |
| Barclays | Overweight | 2026-10-29 | $405 | 3 | 3 | 6 | 1 of 1 |
| KeyBanc | Overweight | 2026-10-29 | $385 | 4 | 13 | 17 | 1 of 1 |
| Piper Sandler | Overweight | 2026-10-29 | $345 | 1 | 12 | 13 | 1 of 1 |
| Truist Securities | Buy | 2026-10-29 | $410 | 4 | 6 | 10 | 1 of 1 |
| Evercore ISI Group | Outperform | 2026-09-17 | $450 | 2 | 3 | 5 | 1 of 1 |
| Stifel | Buy | 2026-05-01 | $420 | 2 | 6 | 8 | 1 of 1 |
| Rosenblatt | Buy | 2026-10-29 | $380 | 4 | 4 | 8 | — |
| DA Davidson | Neutral | 2026-10-29 | $300 | 4 | 2 | 6 | — |
| Loop Capital | Buy | 2025-11-18 | $320 | 1 | 0 | 1 | — |
| Wolfe Research | Outperform | 2025-10-30 | $350 | 2 | 0 | 2 | 1 of 1 |
| UBS | Neutral | 2026-10-29 | $332 | 3 | 8 | 11 | — |
| Freedom Broker | Hold | 2026-05-04 | $400 | 2 | 0 | 2 | — |
| Canaccord Genuity | Buy | 2026-04-30 | $450 | 1 | 2 | 3 | 1 of 1 |
| Jefferies | Buy | 2026-02-02 | $400 | 3 | 1 | 4 | 1 of 1 |
| JPMorgan | Overweight | 2026-10-15 | $425 | 3 | 3 | 6 | 1 of 1 |
| Pivotal Research | Buy | 2026-07-23 | $475 | 1 | 1 | 2 | 1 of 1 |
| Goldman Sachs | Buy | 2026-01-13 | $375 | 3 | 0 | 3 | 1 of 1 |
| Bank of America | Buy | 2026-01-13 | $370 | 4 | 5 | 9 | 1 of 1 |
| RBC Capital | Outperform | 2026-10-29 | $400 | 2 | 4 | 6 | 1 of 1 |
| Roth Capital | Buy | 2026-07-23 | $440 | 2 | 2 | 4 | 1 of 1 |
| Guggenheim | Buy | 2026-10-29 | $450 | 3 | 0 | 3 | 1 of 1 |
| Mizuho | Outperform | 2026-05-06 | $460 | 2 | 2 | 4 | 1 of 1 |
| Susquehanna | Positive | 2026-10-29 | $400 | 1 | 2 | 3 | 1 of 1 |
| Tigress Financial | Strong Buy | 2026-09-18 | $485 | 1 | 2 | 3 | 1 of 1 |
| Bernstein | Market Perform | 2026-04-30 | $390 | 3 | 0 | 3 | — |
| HSBC | Buy | 2026-06-02 | $420 | 1 | 0 | 1 | 1 of 1 |
| Argus Research | Buy | 2026-02-06 | $385 | 1 | 0 | 1 | — |
| BNP Paribas Exane | Outperform | 2025-11-24 | $355 | 1 | 0 | 1 | — |
Counts for one firm on one stock are small and move together; they are a record, not a grade. Neither the firms nor GOOGL carry a letter here. Why →
Every call, last 12 months
| Date | Firm | Rating | Action | Price at call | Target | Target status | Move in the 30 days before |
|---|---|---|---|---|---|---|---|
| 2026-10-29 | RBC Capital | Outperform | maintained | $282.94 | $400 | running to 2027-10-29 | -17.0% |
| 2026-10-29 | UBS | Neutral | maintained | $282.94 | $332 | running to 2027-10-29 | -17.0% |
| 2026-10-29 | Morgan Stanley | Overweight | maintained | $282.94 | $375 | running to 2028-04-29 | -17.0% |
| 2026-10-29 | DA Davidson | Neutral | maintained | $282.94 | $300 | running to 2027-10-29 | -17.0% |
| 2026-10-29 | Citizens | Market Outperform → Market Perform | downgrade | $282.94 | — | no target | -17.0% |
| 2026-10-29 | Barclays | Overweight | maintained | $282.94 | $405 | running to 2027-10-29 | -17.0% |
| 2026-10-29 | Wedbush | Outperform | maintained | $282.94 | $387 | running to 2027-10-29 | -17.0% |
| 2026-10-29 | Truist Securities | Buy | maintained | $282.94 | $410 | running to 2027-10-29 | -17.0% |
| 2026-10-29 | Guggenheim | Buy | reiterated | $282.94 | $450 | running to 2027-10-29 | -17.0% |
| 2026-10-29 | Piper Sandler | Overweight | maintained | $282.94 | $345 | running to 2027-10-29 | -17.0% |
| 2026-10-29 | KeyBanc | Overweight | maintained | $282.94 | $385 | running to 2027-10-29 | -17.0% |
| 2026-10-29 | Susquehanna | Positive | maintained | $282.94 | $400 | running to 2027-10-29 | -17.0% |
| 2026-10-29 | Needham | Buy | reiterated | $282.94 | $450 | running to 2027-10-29 | -17.0% |
| 2026-10-29 | Rosenblatt | Buy | maintained | $282.94 | $380 | running to 2027-10-29 | -17.0% |
| 2026-10-29 | Cantor Fitzgerald | Overweight | maintained | $282.94 | $350 | running to 2027-10-29 | -17.0% |
| 2026-10-22 | Citizens | Market Outperform | maintained | $324.22 | $450 | running to 2027-10-22 | -7.7% |
| 2026-10-20 | BMO Capital | Outperform | maintained | $340.28 | $480 | running to 2027-10-20 | -2.6% |
| 2026-10-19 | KeyBanc | Overweight | maintained | $344.18 | $410 | replaced 2026-10-29, new $385 | -1.5% |
| 2026-10-15 | JPMorgan | Overweight | maintained | $349.22 | $425 | running to 2027-10-15 | +1.2% |
| 2026-10-14 | UBS | Neutral | maintained | $347.64 | $380 | replaced 2026-10-29, new $332 | -0.5% |
| 2026-10-12 | Cantor Fitzgerald | Overweight | reiterated | $352.72 | $420 | replaced 2026-10-29, new $350 | +4.2% |
| 2026-10-08 | Needham | Buy | reiterated | $348.29 | $450 | running to 2027-10-08 | +2.9% |
| 2026-10-06 | Wells Fargo | Overweight | maintained | $347.68 | $417 | running to 2027-10-06 | +2.7% |
| 2026-09-28 | Piper Sandler | Overweight | reiterated | $342.75 | $400 | replaced 2026-10-29, new $345 | -1.1% |
| 2026-09-18 | Tigress Financial | Strong Buy | maintained | $349.54 | $485 | running to 2027-09-18 | +1.4% |
| 2026-09-17 | Evercore ISI Group | Outperform | maintained | $347.33 | $450 | running to 2027-09-17 | +0.9% |
| 2026-09-03 | Rosenblatt | Buy | maintained | $342.48 | $410 | replaced 2026-10-29, new $380 | -9.3% |
| 2026-07-23 | UBS | Neutral | maintained | $317.69 | $379 | replaced 2026-10-14, new $380 | -8.2% |
| 2026-07-23 | Morgan Stanley | Overweight | maintained | $317.69 | $400 | replaced 2026-10-29, new $375 | -8.2% |
| 2026-07-23 | Truist Securities | Buy | maintained | $317.69 | $420 | replaced 2026-10-29, new $410 | -8.2% |
| 2026-07-23 | BMO Capital | Outperform | maintained | $317.69 | $465 | replaced 2026-10-20, new $480 | -8.2% |
| 2026-07-23 | DA Davidson | Neutral | maintained | $317.69 | $350 | reached 2026-07-31 | -8.2% |
| 2026-07-23 | RBC Capital | Outperform | reiterated | $317.69 | $425 | replaced 2026-10-29, new $400 | -8.2% |
| 2026-07-23 | Roth Capital | Buy | maintained | $317.69 | $440 | running to 2027-07-23 | -8.2% |
| 2026-07-23 | Barclays | Overweight | maintained | $317.69 | $425 | replaced 2026-10-29, new $405 | -8.2% |
| 2026-07-23 | Wedbush | Outperform | reiterated | $317.69 | $445 | replaced 2026-10-29, new $387 | -8.2% |
| 2026-07-23 | Wells Fargo | Overweight | maintained | $317.69 | $411 | replaced 2026-10-06, new $417 | -8.2% |
| 2026-07-23 | Cantor Fitzgerald | Overweight | maintained | $317.69 | $420 | replaced 2026-10-29, new $350 | -8.2% |
| 2026-07-23 | Piper Sandler | Overweight | reiterated | $317.69 | $395 | replaced 2026-09-28, new $400 | -8.2% |
| 2026-07-23 | Rosenblatt | Neutral | maintained | $317.69 | $393 | replaced 2026-09-03, new $410 | -8.2% |
| 2026-07-23 | Pivotal Research | Buy | maintained | $317.69 | $475 | running to 2027-07-23 | -8.2% |
| 2026-07-22 | Citizens | Market Outperform | reiterated | $342.09 | $515 | replaced 2026-10-22, new $450 | -2.2% |
| 2026-07-21 | Wells Fargo | Overweight | maintained | $347.15 | $438 | replaced 2026-07-23, new $411 | -5.7% |
| 2026-07-17 | BMO Capital | Outperform | maintained | $346.77 | $455 | replaced 2026-07-23, new $465 | -4.7% |
| 2026-07-13 | UBS | Neutral | maintained | $352.51 | $400 | replaced 2026-07-23, new $379 | -2.0% |
| 2026-07-10 | KeyBanc | Overweight | maintained | $357.18 | $445 | replaced 2026-10-19, new $410 | +0.2% |
| 2026-07-02 | Wells Fargo | Overweight | maintained | $359.91 | $416 | replaced 2026-07-21, new $438 | -0.5% |
| 2026-06-30 | Morgan Stanley | Overweight | maintained | $357.37 | $415 | replaced 2026-07-23, new $400 | -6.0% |
| 2026-06-03 | Needham | Buy | reiterated | $358.99 | $450 | running to 2027-06-03 | -6.3% |
| 2026-06-02 | HSBC | Buy | maintained | $361.85 | $420 | running to 2027-06-02 | -6.2% |
| 2026-06-01 | Piper Sandler | Overweight | maintained | $376.37 | $445 | replaced 2026-07-23, new $395 | -2.4% |
| 2026-05-29 | Truist Securities | Buy | maintained | $380.34 | $430 | replaced 2026-07-23, new $420 | +8.7% |
| 2026-05-21 | Rosenblatt | Neutral | maintained | $387.66 | $393 | within 5% of price when set | +16.7% |
| 2026-05-20 | KeyBanc | Overweight | reiterated | $388.91 | $425 | replaced 2026-07-10, new $445 | +15.3% |
| 2026-05-20 | Citizens | Market Outperform | reiterated | $388.91 | $515 | replaced 2026-10-22, new $450 | +15.3% |
| 2026-05-20 | Wells Fargo | Overweight | maintained | $388.91 | $435 | replaced 2026-07-02, new $416 | +15.3% |
| 2026-05-20 | Needham | Buy | reiterated | $388.91 | $450 | running to 2027-05-20 | +15.3% |
| 2026-05-06 | Mizuho | Outperform | maintained | $398.04 | $460 | running to 2027-05-06 | +32.7% |
| 2026-05-04 | Citizens | Market Outperform | maintained | $383.25 | $515 | replaced 2026-10-22, new $450 | +29.6% |
| 2026-05-04 | Freedom Broker | Buy → Hold | downgrade | $383.25 | $400 | within 5% of price when set | +29.6% |
| 2026-05-01 | Stifel | Buy | maintained | $385.69 | $420 | running to 2027-05-01 | +29.7% |
| 2026-05-01 | Wells Fargo | Overweight | maintained | $385.69 | $427 | replaced 2026-05-20, new $435 | +29.7% |
| 2026-04-30 | Canaccord Genuity | Buy | maintained | $384.80 | $450 | running to 2027-04-30 | +33.8% |
| 2026-04-30 | UBS | Neutral | maintained | $384.80 | $410 | replaced 2026-07-13, new $400 | +33.8% |
| 2026-04-30 | Bernstein | Market Perform | maintained | $384.80 | $390 | within 5% of price when set | +33.8% |
| 2026-04-30 | Citigroup | Buy | maintained | $384.80 | $447 | running to 2027-04-30 | +33.8% |
| 2026-04-30 | Morgan Stanley | Overweight | maintained | $384.80 | $375 | within 5% of price when set | +33.8% |
| 2026-04-30 | Susquehanna | Positive | maintained | $384.80 | $460 | replaced 2026-10-29, new $400 | +33.8% |
| 2026-04-30 | Piper Sandler | Overweight | reiterated | $384.80 | $425 | replaced 2026-06-01, new $445 | +33.8% |
| 2026-04-30 | RBC Capital | Outperform | maintained | $384.80 | $425 | replaced 2026-10-29, new $400 | +33.8% |
| 2026-04-30 | Guggenheim | Buy | maintained | $384.80 | $450 | running to 2027-04-30 | +33.8% |
| 2026-04-30 | Evercore ISI Group | Outperform | maintained | $384.80 | $420 | replaced 2026-09-17, new $450 | +33.8% |
| 2026-04-30 | Barclays | Overweight | maintained | $384.80 | $405 | replaced 2026-07-23, new $425 | +33.8% |
| 2026-04-30 | Cantor Fitzgerald | Overweight | maintained | $384.80 | $465 | replaced 2026-07-23, new $420 | +33.8% |
| 2026-04-30 | KeyBanc | Overweight | maintained | $384.80 | $425 | replaced 2026-07-10, new $445 | +33.8% |
| 2026-04-30 | Truist Securities | Buy | maintained | $384.80 | $415 | replaced 2026-05-29, new $430 | +33.8% |
| 2026-04-30 | Rosenblatt | Neutral | maintained | $384.80 | $393 | within 5% of price when set | +33.8% |
| 2026-04-30 | Needham | Buy | maintained | $384.80 | $450 | running to 2027-04-30 | +33.8% |
| 2026-04-24 | Needham | Buy | reiterated | $344.40 | $400 | replaced 2026-04-30, new $450 | +18.4% |
| 2026-04-23 | Rosenblatt | Neutral | maintained | $338.89 | $357 | reached 2026-04-30 | +16.7% |
| 2026-04-22 | BMO Capital | Outperform | maintained | $339.32 | $410 | replaced 2026-07-17, new $455 | +12.3% |
| 2026-04-21 | UBS | Neutral | maintained | $332.29 | $375 | reached 2026-04-30 | +10.4% |
| 2026-04-20 | KeyBanc | Overweight | maintained | $337.42 | $380 | reached 2026-04-30 | +12.1% |
| 2026-04-14 | Citigroup | Buy | maintained | $332.91 | $405 | replaced 2026-04-30, new $447 | +10.1% |
| 2026-04-13 | Stifel | Buy | maintained | $321.31 | $387 | replaced 2026-05-01, new $420 | +6.3% |
| 2026-04-13 | Citizens | Market Outperform | reiterated | $321.31 | $385 | reached 2026-05-01 | +6.3% |
| 2026-04-08 | Cantor Fitzgerald | Overweight | reiterated | $317.32 | $370 | reached 2026-04-30 | +3.6% |
| 2026-04-08 | Needham | Buy | reiterated | $317.32 | $400 | replaced 2026-04-30, new $450 | +3.6% |
| 2026-04-02 | Wells Fargo | Overweight | maintained | $295.77 | $361 | reached 2026-04-30 | -2.6% |
| 2026-03-27 | Wells Fargo | Overweight | maintained | $274.34 | $397 | replaced 2026-04-02, new $361 | -12.3% |
| 2026-03-27 | Needham | Buy | reiterated | $274.34 | $400 | replaced 2026-04-30, new $450 | -12.3% |
| 2026-03-13 | Needham | Buy | reiterated | $302.28 | $400 | replaced 2026-04-30, new $450 | -2.8% |
| 2026-02-23 | Wells Fargo | Equal-Weight → Overweight | upgrade | $311.49 | $387 | replaced 2026-03-27, new $397 | -5.0% |
| 2026-02-19 | Tigress Financial | Strong Buy | maintained | $302.85 | $415 | replaced 2026-09-18, new $485 | -6.0% |
| 2026-02-13 | Freedom Broker | Buy | maintained | $305.72 | $365 | reached 2026-04-30 | -9.0% |
| 2026-02-06 | Citigroup | Buy | maintained | $322.86 | $390 | replaced 2026-04-14, new $405 | +0.3% |
| 2026-02-06 | Argus Research | Buy | maintained | $322.86 | $385 | reached 2026-05-01 | +0.3% |
| 2026-02-05 | DA Davidson | Neutral | maintained | $331.25 | $310 | reached 2026-02-12 | +5.4% |
| 2026-02-05 | JPMorgan | Overweight | maintained | $331.25 | $395 | reached 2026-05-06 | +5.4% |
| 2026-02-05 | Stifel | Buy | reiterated | $331.25 | $395 | replaced 2026-04-13, new $387 | +5.4% |
| 2026-02-05 | Piper Sandler | Overweight | reiterated | $331.25 | $395 | replaced 2026-04-30, new $425 | +5.4% |
| 2026-02-05 | Barclays | Overweight | maintained | $331.25 | $360 | reached 2026-04-30 | +5.4% |
| 2026-02-05 | UBS | Neutral | maintained | $331.25 | $348 | replaced 2026-04-21, new $375 | +5.4% |
| 2026-02-05 | RBC Capital | Outperform | maintained | $331.25 | $400 | replaced 2026-04-30, new $425 | +5.4% |
| 2026-02-05 | Evercore ISI Group | Outperform | maintained | $331.25 | $400 | replaced 2026-04-30, new $420 | +5.4% |
| 2026-02-05 | Cantor Fitzgerald | Overweight | reiterated | $331.25 | $370 | reached 2026-04-30 | +5.4% |
| 2026-02-05 | Wells Fargo | Equal-Weight | maintained | $331.25 | $354 | replaced 2026-02-23, new $387 | +5.4% |
| 2026-02-05 | Citizens | Market Outperform | reiterated | $331.25 | $385 | reached 2026-05-01 | +5.4% |
| 2026-02-05 | Wedbush | Outperform | maintained | $331.25 | $370 | reached 2026-04-30 | +5.4% |
| 2026-02-05 | KeyBanc | Overweight | maintained | $331.25 | $370 | replaced 2026-04-20, new $380 | +5.4% |
| 2026-02-05 | Mizuho | Outperform | maintained | $331.25 | $410 | replaced 2026-05-06, new $460 | +5.4% |
| 2026-02-05 | Rosenblatt | Neutral | maintained | $331.25 | $357 | reached 2026-04-30 | +5.4% |
| 2026-02-05 | Pivotal Research | Buy | maintained | $331.25 | $420 | replaced 2026-07-23, new $475 | +5.4% |
| 2026-02-05 | Needham | Buy | maintained | $331.25 | $400 | replaced 2026-04-30, new $450 | +5.4% |
| 2026-02-05 | Roth Capital | Buy | maintained | $331.25 | $395 | reached 2026-05-06 | +5.4% |
| 2026-02-02 | Jefferies | Buy | maintained | $343.69 | $400 | reached 2026-05-08 | +9.1% |
| 2026-01-27 | Roth Capital | Buy | maintained | $334.55 | $365 | replaced 2026-02-05, new $395 | +6.7% |
| 2026-01-26 | KeyBanc | Overweight | maintained | $333.26 | $360 | replaced 2026-02-05, new $370 | +6.3% |
| 2026-01-26 | Needham | Buy | reiterated | $333.26 | $330 | within 5% of price when set | +6.3% |
| 2026-01-23 | Stifel | Buy | maintained | $327.93 | $346 | replaced 2026-02-05, new $395 | +4.4% |
| 2026-01-20 | UBS | Neutral | maintained | $322.00 | $345 | replaced 2026-02-05, new $348 | +4.8% |
| 2026-01-13 | Goldman Sachs | Buy | maintained | $335.97 | $375 | reached 2026-04-30 | +8.6% |
| 2026-01-13 | Bank of America | Buy | maintained | $335.97 | $370 | reached 2026-04-30 | +8.6% |
| 2026-01-12 | Wells Fargo | Equal-Weight | maintained | $331.86 | $350 | replaced 2026-02-05, new $354 | +7.3% |
| 2026-01-09 | Mizuho | Outperform | maintained | $328.57 | $365 | replaced 2026-02-05, new $410 | +2.6% |
| 2026-01-08 | Cantor Fitzgerald | Neutral → Overweight | upgrade | $325.44 | $370 | reached 2026-04-30 | +2.6% |
| 2026-01-07 | Canaccord Genuity | Buy | maintained | $321.98 | $390 | replaced 2026-04-30, new $450 | +2.6% |
| 2026-01-05 | Jefferies | Buy | maintained | $316.54 | $365 | replaced 2026-02-02, new $400 | -1.5% |
| 2025-12-31 | Citizens | Market Outperform | maintained | $313.00 | $385 | reached 2026-05-01 | -0.6% |
| 2025-12-22 | Citigroup | Buy | maintained | $309.78 | $350 | replaced 2026-02-06, new $390 | +3.4% |
| 2025-12-19 | Wedbush | Outperform | maintained | $307.16 | $350 | replaced 2026-02-05, new $370 | +4.9% |
| 2025-12-16 | BMO Capital | Outperform | maintained | $306.57 | $343 | reached 2026-02-02 | +10.9% |
| 2025-12-12 | JPMorgan | Overweight | maintained | $309.29 | $385 | replaced 2026-02-05, new $395 | +7.9% |
| 2025-12-11 | Piper Sandler | Overweight | maintained | $312.43 | $365 | replaced 2026-02-05, new $395 | +7.2% |
| 2025-12-05 | Truist Securities | Buy | maintained | $321.27 | $350 | reached 2026-04-27 | +13.0% |
| 2025-12-01 | Guggenheim | Buy | maintained | $314.89 | $375 | reached 2026-04-30 | +12.0% |
| 2025-11-25 | DA Davidson | Neutral | maintained | $323.44 | $300 | reached 2025-12-17 | — |
| 2025-11-24 | BNP Paribas Exane | Outperform | initiated | $318.58 | $355 | reached 2026-04-30 | — |
| 2025-11-18 | Loop Capital | Hold → Buy | upgrade | $284.28 | $320 | reached 2025-11-25 | — |
| 2025-11-10 | Freedom Broker | Buy | maintained | $290.10 | $325 | reached 2026-01-08 | — |
| 2025-10-30 | DA Davidson | Neutral | maintained | $281.48 | $300 | reached 2025-11-24 | — |
| 2025-10-30 | Wolfe Research | Outperform | maintained | $281.48 | $350 | reached 2026-04-27 | — |
| 2025-10-30 | Wedbush | Outperform | maintained | $281.48 | $320 | reached 2025-11-25 | — |
| 2025-10-30 | UBS | Neutral | maintained | $281.48 | $306 | reached 2025-11-24 | — |
| 2025-10-30 | Citigroup | Buy | maintained | $281.48 | $343 | replaced 2025-12-22, new $350 | — |
| 2025-10-30 | Morgan Stanley | Overweight | maintained | $281.48 | $330 | reached 2026-01-12 | — |
| 2025-10-30 | Bernstein | Market Perform | maintained | $281.48 | $305 | reached 2025-11-24 | — |
| 2025-10-30 | Evercore ISI Group | Outperform | maintained | $281.48 | $325 | reached 2026-01-08 | — |
| 2025-10-30 | Barclays | Overweight | maintained | $281.48 | $315 | reached 2025-11-24 | — |
| 2025-10-30 | Goldman Sachs | Buy | maintained | $281.48 | $330 | reached 2026-01-12 | — |
| 2025-10-30 | Wells Fargo | Equal-Weight | maintained | $281.48 | $268 | within 5% of price when set | — |
| 2025-10-30 | Cantor Fitzgerald | Neutral | maintained | $281.48 | $310 | reached 2025-11-24 | — |
| 2025-10-30 | Canaccord Genuity | Buy | maintained | $281.48 | $330 | replaced 2026-01-07, new $390 | — |
| 2025-10-30 | Piper Sandler | Overweight | reiterated | $281.48 | $330 | replaced 2025-12-11, new $365 | — |
| 2025-10-30 | KeyBanc | Overweight | maintained | $281.48 | $330 | reached 2026-01-12 | — |
| 2025-10-30 | Truist Securities | Buy | maintained | $281.48 | $320 | reached 2025-11-25 | — |
| 2025-10-30 | Jefferies | Buy | maintained | $281.48 | $320 | reached 2025-11-25 | — |
| 2025-10-30 | Needham | Buy | maintained | $281.48 | $330 | reached 2026-01-12 | — |
| 2025-10-30 | Rosenblatt | Neutral | maintained | $281.48 | $279 | within 5% of price when set | — |
| 2025-10-30 | Bank of America | Buy | maintained | $281.48 | $335 | reached 2026-01-13 | — |
Interactive version with the price chart and target overlay: Scorecard tab on the dashboard. All covered names: index.
How calls are checked
Every call is checked on the firm's own terms. A price target is followed until its own deadline (12 months unless the firm publishes a different horizon) and ends as reached (the stock closed at or beyond it while it stood), replaced (the same firm set a new target first) or short at deadline. A rating is compared with the stock's sector SPDR ETF on total return over the rating's life, because most big-firm ratings are relative: Overweight means "beat its peers", not "go up". Hold-type ratings are tracked, not graded. A firm is numbered only with 30+ resolved targets, and a letter prints only for a firm's whole record where an exact test separates it from a coin flip. None of this is a verdict on anyone's skill, and one day is never a grade. The full method →
Get the daily brief
Our take, the S&P 500 Pulse, the Street's calls and today's docket — one email, weekdays, 9 AM ET, 30 minutes before the open.